The global Microbial API market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Microbial APIs (Application Programming Interfaces) refer to software interfaces that allow developers to interact with microbial data and perform various operations using that data. APIs can provide access to a range of microbial data, such as genomic data, microbiome data, and other types of microbiological data.

Microbial APIs can be used for a variety of purposes, including research, drug discovery, diagnostics, and more. For example, researchers can use microbial APIs to analyze microbial genomic data to better understand the role of specific genes in microbial function or to identify potential drug targets. Similarly, pharmaceutical companies can use microbial APIs to screen potential drug candidates against a database of microbial genomes to identify compounds with antimicrobial properties.

There are several microbial APIs available, including NCBI"s Entrez API, KEGG API, and IMG API, among others. These APIs provide access to a wealth of microbial data and can be used in a variety of programming languages, making it easy for developers to integrate microbial data into their applications.

United States market for Microbial API is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Microbial API is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Microbial API is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Microbial API players cover DSM, Merck & Co., Inc., HGPF, Huaxing, Tianjin Tianyao Pharmaceuticals Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Microbial API Industry Forecast” looks at past sales and reviews total world Microbial API sales in 2024, providing a comprehensive analysis by region and market sector of projected Microbial API sales for 2025 through 2031. With Microbial API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microbial API industry.

This Insight Report provides a comprehensive analysis of the global Microbial API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Microbial API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microbial API market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microbial API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microbial API.

This report presents a comprehensive overview, market shares, and growth opportunities of Microbial API market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Antibiotics

    Amino acids

    Vitamins

    Nucleotides

    Organic Acids

    Hormones

Segmentation by Application:

    Hospitals

    Research and Academic Laboratories

    Pharmaceutical and Biotechnology Companies

This report also splits the market by region:

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

    UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    DSM

    Merck & Co., Inc.

    HGPF

    Huaxing

    Tianjin Tianyao Pharmaceuticals Co., Ltd.

    CSPC Pharma

    KOLON LIFE SCIENCE

    Northeast Pharm

    Topfond Pharmaceutical Co., Ltd.

    Shandong Lukang Pharmaceutical Co., Ltd.

    Luwei Pharmaceutical Group Co., Ltd.

    North China Pharmaceutical Co Ltd

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Microbial API Market Size (2020-2031)
        2.1.2 Microbial API Market Size CAGR by Region (2020 VS 2024 VS 2031)
        2.1.3 World Current & Future Analysis for Microbial API by Country/Region (2020, 2024 & 2031)
    2.2 Microbial API Segment by Type
        2.2.1 Antibiotics
        2.2.2 Amino acids
        2.2.3 Vitamins
        2.2.4 Nucleotides
        2.2.5 Organic Acids
        2.2.6 Hormones
    2.3 Microbial API Market Size by Type
        2.3.1 Microbial API Market Size CAGR by Type (2020 VS 2024 VS 2031)
        2.3.2 Global Microbial API Market Size Market Share by Type (2020-2025)
    2.4 Microbial API Segment by Application
        2.4.1 Hospitals
        2.4.2 Research and Academic Laboratories
        2.4.3 Pharmaceutical and Biotechnology Companies
    2.5 Microbial API Market Size by Application
        2.5.1 Microbial API Market Size CAGR by Application (2020 VS 2024 VS 2031)
        2.5.2 Global Microbial API Market Size Market Share by Application (2020-2025)

3 Microbial API Market Size by Player
    3.1 Microbial API Market Size Market Share by Player
        3.1.1 Global Microbial API Revenue by Player (2020-2025)
        3.1.2 Global Microbial API Revenue Market Share by Player (2020-2025)
    3.2 Global Microbial API Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Microbial API by Region
    4.1 Microbial API Market Size by Region (2020-2025)
    4.2 Global Microbial API Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Microbial API Market Size Growth (2020-2025)
    4.4 APAC Microbial API Market Size Growth (2020-2025)
    4.5 Europe Microbial API Market Size Growth (2020-2025)
    4.6 Middle East & Africa Microbial API Market Size Growth (2020-2025)

5 Americas
    5.1 Americas Microbial API Market Size by Country (2020-2025)
    5.2 Americas Microbial API Market Size by Type (2020-2025)
    5.3 Americas Microbial API Market Size by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Microbial API Market Size by Region (2020-2025)
    6.2 APAC Microbial API Market Size by Type (2020-2025)
    6.3 APAC Microbial API Market Size by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Microbial API Market Size by Country (2020-2025)
    7.2 Europe Microbial API Market Size by Type (2020-2025)
    7.3 Europe Microbial API Market Size by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Microbial API by Region (2020-2025)
    8.2 Middle East & Africa Microbial API Market Size by Type (2020-2025)
    8.3 Middle East & Africa Microbial API Market Size by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Global Microbial API Market Forecast
    10.1 Global Microbial API Forecast by Region (2026-2031)
        10.1.1 Global Microbial API Forecast by Region (2026-2031)
        10.1.2 Americas Microbial API Forecast
        10.1.3 APAC Microbial API Forecast
        10.1.4 Europe Microbial API Forecast
        10.1.5 Middle East & Africa Microbial API Forecast
    10.2 Americas Microbial API Forecast by Country (2026-2031)
        10.2.1 United States Market Microbial API Forecast
        10.2.2 Canada Market Microbial API Forecast
        10.2.3 Mexico Market Microbial API Forecast
        10.2.4 Brazil Market Microbial API Forecast
    10.3 APAC Microbial API Forecast by Region (2026-2031)
        10.3.1 China Microbial API Market Forecast
        10.3.2 Japan Market Microbial API Forecast
        10.3.3 Korea Market Microbial API Forecast
        10.3.4 Southeast Asia Market Microbial API Forecast
        10.3.5 India Market Microbial API Forecast
        10.3.6 Australia Market Microbial API Forecast
    10.4 Europe Microbial API Forecast by Country (2026-2031)
        10.4.1 Germany Market Microbial API Forecast
        10.4.2 France Market Microbial API Forecast
        10.4.3 UK Market Microbial API Forecast
        10.4.4 Italy Market Microbial API Forecast
        10.4.5 Russia Market Microbial API Forecast
    10.5 Middle East & Africa Microbial API Forecast by Region (2026-2031)
        10.5.1 Egypt Market Microbial API Forecast
        10.5.2 South Africa Market Microbial API Forecast
        10.5.3 Israel Market Microbial API Forecast
        10.5.4 Turkey Market Microbial API Forecast
    10.6 Global Microbial API Forecast by Type (2026-2031)
    10.7 Global Microbial API Forecast by Application (2026-2031)
        10.7.1 GCC Countries Market Microbial API Forecast

11 Key Players Analysis
    11.1 DSM
        11.1.1 DSM Company Information
        11.1.2 DSM Microbial API Product Offered
        11.1.3 DSM Microbial API Revenue, Gross Margin and Market Share (2020-2025)
        11.1.4 DSM Main Business Overview
        11.1.5 DSM Latest Developments
    11.2 Merck & Co., Inc.
        11.2.1 Merck & Co., Inc. Company Information
        11.2.2 Merck & Co., Inc. Microbial API Product Offered
        11.2.3 Merck & Co., Inc. Microbial API Revenue, Gross Margin and Market Share (2020-2025)
        11.2.4 Merck & Co., Inc. Main Business Overview
        11.2.5 Merck & Co., Inc. Latest Developments
    11.3 HGPF
        11.3.1 HGPF Company Information
        11.3.2 HGPF Microbial API Product Offered
        11.3.3 HGPF Microbial API Revenue, Gross Margin and Market Share (2020-2025)
        11.3.4 HGPF Main Business Overview
        11.3.5 HGPF Latest Developments
    11.4 Huaxing
        11.4.1 Huaxing Company Information
        11.4.2 Huaxing Microbial API Product Offered
        11.4.3 Huaxing Microbial API Revenue, Gross Margin and Market Share (2020-2025)
        11.4.4 Huaxing Main Business Overview
        11.4.5 Huaxing Latest Developments
    11.5 Tianjin Tianyao Pharmaceuticals Co., Ltd.
        11.5.1 Tianjin Tianyao Pharmaceuticals Co., Ltd. Company Information
        11.5.2 Tianjin Tianyao Pharmaceuticals Co., Ltd. Microbial API Product Offered
        11.5.3 Tianjin Tianyao Pharmaceuticals Co., Ltd. Microbial API Revenue, Gross Margin and Market Share (2020-2025)
        11.5.4 Tianjin Tianyao Pharmaceuticals Co., Ltd. Main Business Overview
        11.5.5 Tianjin Tianyao Pharmaceuticals Co., Ltd. Latest Developments
    11.6 CSPC Pharma
        11.6.1 CSPC Pharma Company Information
        11.6.2 CSPC Pharma Microbial API Product Offered
        11.6.3 CSPC Pharma Microbial API Revenue, Gross Margin and Market Share (2020-2025)
        11.6.4 CSPC Pharma Main Business Overview
        11.6.5 CSPC Pharma Latest Developments
    11.7 KOLON LIFE SCIENCE
        11.7.1 KOLON LIFE SCIENCE Company Information
        11.7.2 KOLON LIFE SCIENCE Microbial API Product Offered
        11.7.3 KOLON LIFE SCIENCE Microbial API Revenue, Gross Margin and Market Share (2020-2025)
        11.7.4 KOLON LIFE SCIENCE Main Business Overview
        11.7.5 KOLON LIFE SCIENCE Latest Developments
    11.8 Northeast Pharm
        11.8.1 Northeast Pharm Company Information
        11.8.2 Northeast Pharm Microbial API Product Offered
        11.8.3 Northeast Pharm Microbial API Revenue, Gross Margin and Market Share (2020-2025)
        11.8.4 Northeast Pharm Main Business Overview
        11.8.5 Northeast Pharm Latest Developments
    11.9 Topfond Pharmaceutical Co., Ltd.
        11.9.1 Topfond Pharmaceutical Co., Ltd. Company Information
        11.9.2 Topfond Pharmaceutical Co., Ltd. Microbial API Product Offered
        11.9.3 Topfond Pharmaceutical Co., Ltd. Microbial API Revenue, Gross Margin and Market Share (2020-2025)
        11.9.4 Topfond Pharmaceutical Co., Ltd. Main Business Overview
        11.9.5 Topfond Pharmaceutical Co., Ltd. Latest Developments
    11.10 Shandong Lukang Pharmaceutical Co., Ltd.
        11.10.1 Shandong Lukang Pharmaceutical Co., Ltd. Company Information
        11.10.2 Shandong Lukang Pharmaceutical Co., Ltd. Microbial API Product Offered
        11.10.3 Shandong Lukang Pharmaceutical Co., Ltd. Microbial API Revenue, Gross Margin and Market Share (2020-2025)
        11.10.4 Shandong Lukang Pharmaceutical Co., Ltd. Main Business Overview
        11.10.5 Shandong Lukang Pharmaceutical Co., Ltd. Latest Developments
    11.11 Luwei Pharmaceutical Group Co., Ltd.
        11.11.1 Luwei Pharmaceutical Group Co., Ltd. Company Information
        11.11.2 Luwei Pharmaceutical Group Co., Ltd. Microbial API Product Offered
        11.11.3 Luwei Pharmaceutical Group Co., Ltd. Microbial API Revenue, Gross Margin and Market Share (2020-2025)
        11.11.4 Luwei Pharmaceutical Group Co., Ltd. Main Business Overview
        11.11.5 Luwei Pharmaceutical Group Co., Ltd. Latest Developments
    11.12 North China Pharmaceutical Co Ltd
        11.12.1 North China Pharmaceutical Co Ltd Company Information
        11.12.2 North China Pharmaceutical Co Ltd Microbial API Product Offered
        11.12.3 North China Pharmaceutical Co Ltd Microbial API Revenue, Gross Margin and Market Share (2020-2025)
        11.12.4 North China Pharmaceutical Co Ltd Main Business Overview
        11.12.5 North China Pharmaceutical Co Ltd Latest Developments

12 Research Findings and Conclusion